Inhibition of human α7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors

British Journal of Pharmacology

Volumn 140, Issue 7, 2003, Pages 1313-1319

  Maskell, Peter D ^a,c   Speder, Pauline ^a   Newberry, Nigel R ^b   Bermudez, Isabel ^a  

^a OXFORD BROOKES UNIVERSITY   (United Kingdom)

^b Vernalis PLC   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cerestat; Memantine; Nicotinic acetylcholine receptors; NMDA receptor open channel blockers

Indexed keywords

APTIGANEL; BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RECEPTOR; IODINE 125; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; IC 50; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; VOLTAGE CLAMP; XENOPUS;

ACETYLCHOLINE; ANIMALS; BUNGAROTOXINS; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; GUANIDINES; HUMANS; IODINE RADIOISOTOPES; MEMANTINE; OOCYTES; PATCH-CLAMP TECHNIQUES; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; XENOPUS;

EID: 1642422286     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705559     Document Type: Article

References (41)

1. ALBERS, G.W., GOLDSTEIN, L.B., HALL, D. & LESKO, L.M. (2001). Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA, 286, 2673-2682.
2. BARIK, J., HOULIHAN, L.M., BERMUDEZ, I. & SLATER, Y. (2002). Tropisetron (1CS 205-930) interacts with human nicotinic acetylcholine receptors. Br. J. Pharmacol., 135, P373.
3. BUISSON, B. & BERTRAND, D. (1998). Open-channel blockers at the human α4β2 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol, 53, 555-563.
4. CARLSON, N.G., BACCHI, A., ROGERS, S.W. & GAHRING, L.C. (1998). Nicotine blocks TNF-alpha-mediated neuroprotection to NMDA by an alpha-bungarotoxin sensitive pathway. J. Neurobiol., 35, 29-36.
5. CHAMPTIAUX, N., GOTTI, C., CORDERO-ERAUSQUIN, M., DAVID, D.J., PRZYBYLSKI, C., LENA, C., CLEMENTI, F., MORETTI, M., ROSSI, F.M., LE NOVÈRE, N., MCINTOSH, M., GARDIER, A.M. & CHANGEUX, J.P. (2003). Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J. Neurosci., 23, 7820-7829.
6. CHEN, H.S.V., PELLEGRINI, J.W., AGGARWAL, S.K., LEI, S.Z., WARACH, S., JENSEN, F.E. & LIPTON, S.A. (1992). Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine - therapeutic advantage against NMDA receptor mediated neurotoxicity. J. Neurosci., 12, 4427-4436.
7. CONNOLLY, J., BOULTER, J. & HEINEMANN, S.F. (1992). 4-2β2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs. Br. J. Pharmacol., 105, 657-666.
8. CONROY, W.G. & BERG, D.K. (1998). Nicotinic receptor subtypes in the developing chick brain: appearance of a species containing the α4. β2 and α5 gene products. Mol. Pharmacol., 53, 392-401.
9. 2+ dependent mechanism. Neuropharmacology., 39, 2799-2807.
10. DANYSZ, W., PARSONS, C.G., KORNHUBER, J., SCHMIDT, W.J. & QUACK, G. (1997). Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci. Biobehav. Rev., 21, 455-468.
11. FRYER, J.D. & LUKAS, R.J. (1999). Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function. J. Neurochem., 72, 1117-1124.
12. GARCÍA-COLUNGA, J. & MILEDI, R (1999). Modulation of nicotinic acetylcholine receptors by strychnine. Proc. Natl. Acad. Sci. U.S.A., 96, 4113-4118.
13. GOTTI, C., FORNASARI, D. & CLEMENTI, F. (1997). Human neuronal nicotinic receptors. Prog. Neurobiol., 53, 199-237.
14. GROOT-KORMELINK, P.J. & LUYTEN, W.H.M.L. (1997). Cloning and sequence of full-length cDNAs encoding the human neuronal nicotinic acetylcholine receptor (nAChR) subunits β3 and β4 and expression of seven nAChR subunits in the human neuroblastoma cell line SH-SY5Y and/or IMR-32. FEBS Lett., 400, 309-314.
15. HALLIWELL, R.F., PETERS, J.A & LAMBERT, J.J. (1989). The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK801: a voltage-clamp study on neuronal cells in culture. Br. J. Pharmacol., 96, 480-494.
16. 7 neuronal nicotinic receptors by ω-conotoxin MVIIC, ω-conotoxin GVIA and diltiazem. Br. J. Pharmacol., 127, 1375-1387.
17. HOULIHAN, L.M., SLATER, E.Y., BEADLE, D.J., LUKAS, R.J. & BERMUDEZ, I. (2000). Effects of diltiazem on human nicotinic acetylcholine and GABA(A) receptors. Neuropharmacology, 39, 2533-2542.
18. 4β4 nicotinic acetylcholine receptors. J. Neurochem., 78, 1029-1043.
19. KANEKO, S., MAEDA, T., KUME, T., KOCHIAMA, H., AKAIKE, A., SHIMOHAMA, S. & KIMURA, J. (1997). Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors. Brain Res., 765, 135-140.
20. KLINK, R., KERCHOVE D'EXAERDE, A., ZOLI, M. & CHANGEUX, J.-P. (2001). Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci., 21, 1452-1463.
21. LAUDENBACH, V., MEDJA, F., ZOLI, M., ROSSI, F., EVRARD, P., CHANGEUX, J.-P. & GRESSENS, P. (2002). Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries. FASEB J. 16, 423-425.
22. LE NOVÈRE, N., CORRINGER, P.-J. & CHANGEUX, J.-P. (2002). The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J. Neurobiol., 53, 447-456.
23. LOPÉZ, M., FONTERRIZ, R., GANDÍA, L., FUENTE, M., VILLARROYA, M., GARCÍA-SANCHO, J. & GARCÍA, A. (1993). The nicotinic acetylcholine receptor of the bovine chromaffin cell, a new target for dihydropyridines. Eur. J. Pharmacol., 247, 199-207.
24. LUKAS, R.J., CHANGEUX, J.-P., LE NOVÈRE, N., ALBUQUERQUE, E.X., BALFOUR, D.J.K., BERG, D.K., BERTRAND, D., CHIAPPINELLII, V.A., CLARKE, P.B.S., COLLINS, A.C., DANI, J.A., GRADY, S.R., KELLAR, K.J., LINDSTROM, J.M., MARKS, M.J., QUIK, M., TAYLOR, P.W. & WONNACOTT, S. (1999). International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev., 51, 397-401.
25. MANSVELDER, H.D. & MCGEHEE, D.S. (2000). Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron. 27, 349-357.
26. MINEMATSU, K., FISCHER, M., LI, L., DAVIS, M.A., KNAPP, A.G., COTTER, R.E., MCBURNEY, R.N. & SOTAK, C.H. (1993). Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI. Neurology, 43, 397-403.
27. O'DELL, T.J. & CHRISTENSEN, B.N. (1988). Mecamylamine is a selective non-competitive antagonist of N-methyl-D-aspartate and aspartate induced currents in horizontal cells dissociated from the catfish. Neurosci. Lett., 94, 93-98.
28. OLIVER, D., LUDWIG, J., REISINGER, E., ZOELLNER, W., RUPPERSBERG, P. & FAKLER, F. (2001). Memantine inhibits efferent cholinergic transmission in the cochlea by blocking nicotinic acetylcholine receptors of outer hair cells. Mol. Pharmacol., 60, 183-189.
29. PARSONS, C.G., DANYSZ, W., BARTMANN, A., SPIELMANNS, P., FRANKIEWICZ, T., HESSELINK, M., EILBACHER, B. & QUACK, G. (1999a). Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization. Neuropharmacology, 38, 85-108.
30. PARSONS, C.G., DANYSZ, W. & QUACK, G. (1999b). Memantine is a clinically well tolerated NMDA receptor antagonist - review of preclinical data. Neuropharmacology, 38, 735-767.
31. PARSONS, C.G., PANCHENKO, V.A., INCHENKO, V.O., TSYNDRENKO, A.Y. & KRISHTAL, O.A. (1996). Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on NMDA receptor antagonistic effects of amantadine and memantine. Eur. J. Neurosci., 8, 446-454.
32. PENG, X., KATZ, M., GERZANICH, V., ANAND, R. & LINDSTROM, J. (1994). Human α7 acetylcholine receptor: cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional α7 homomers expressed in Xenopus oocytes. Mol. Pharmacol., 45, 546-554.
33. PENG, J-H, LUCERO, L., FRYER, J., HERT, J., LEONARD, S.S. & LUKAS, R.J. (1999). Inducible, heterologous expression of human α7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line. Brain Res., 825, 172-179.
34. RADCLIFFE, K.A. & DANI, J.A. (1998). Nicotine stimulation produces multiple forms of increased glutamatergic synaptic transmission. J. Neurosci., 18, 7075-7083.
35. RADCLIFFE, K.A., FISCHER, J.L., GRAY, R. & DANI, J.A. (1999). Nicotine modulation of glutamate and GABA synaptic transmission of hippocampal neurones. Annal of the New York Academy of Science, 868, 591-610.
36. RAMMES, G., RUPPRECHT, R., FERRARI, U., ZIEGLGANSBERGER, W & PARSONS, C.G. (2001). The N-methyl-D-aspartate receptor channel blocker memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci. Lett.. 306, 81-84.
37. RANA, B., MCMORA, S.O., REEVE, H.L., WYATT, C.N., VAUGHAN, P.F. & PEERS, C. (1993). Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine. Eur. J. Pharmacol., 250, 247-251.
38. RYAN, R.E., DRAGO, J. & LOCAICONO, R.E. (2001). Dose-related neuroprotective effects o chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4-nicotinic receptor subunit knockout mice. Br. J. Pharmacol., 132, 1650-1656.
39. SLATER, Y., HOULIHAN, L.M., CASSELS, B.K., LUKAS, R.J. & BERMUDEZ, I. (2002). Effects of the plant alkaloid tetrandrine on human nicotinic acetylcholine receptors. Eur. J. Pharmacol., 450, 213-221.
40. ZOLI, M., MORETTI, M., ZANARDI, A., MCINTOSH, M., CLEMENTI, F. & GOTTI, C. (2002). Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J. Neurosci., 22, 8785-8789.
41. ZOLI, M., PICCIOTTO, M.R., ERRARI, R., COCCHI, D. & CHANGEUX, J.-P. (1999). Increased neurodegeneration during aging in mice lacking high-affinity nicotinic receptors. EMBO J., 18, 1235-1244.